These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31590270)

  • 1. Line Scan Raman Microspectroscopy for Label-Free Diagnosis of Human Pituitary Biopsies.
    Bovenkamp D; Micko A; Püls J; Placzek F; Höftberger R; Vila G; Leitgeb R; Drexler W; Andreana M; Wolfsberger S; Unterhuber A
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31590270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morpho-Molecular Metabolic Analysis and Classification of Human Pituitary Gland and Adenoma Biopsies Based on Multimodal Optical Imaging.
    Giardina G; Micko A; Bovenkamp D; Krause A; Placzek F; Papp L; Krajnc D; Spielvogel CP; Winklehner M; Höftberger R; Vila G; Andreana M; Leitgeb R; Drexler W; Wolfsberger S; Unterhuber A
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rab3B immunoexpression in human pituitary adenomas.
    Rotondo F; Scheithauer BW; Kovacs K; Bell DC
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):185-8. PubMed ID: 19384079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the 2017 WHO Classification of Pituitary Tumors.
    Mete O; Lopes MB
    Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of line-scan Raman microscopy for high-throughput chemical imaging of cell population.
    Qi J; Shih WC
    Appl Opt; 2014 May; 53(13):2881-5. PubMed ID: 24921875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double separate versus contiguous pituitary adenomas: MRI features and endocrinological follow up.
    Roberts S; Borges MT; Lillehei KO; Kleinschmidt-DeMasters BK
    Pituitary; 2016 Oct; 19(5):472-81. PubMed ID: 27209585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite somatotroph--ACTH-immunoreactive pituitary adenoma with transformation of hyperplasia to adenoma.
    Mazarakis N; Kontogeorgos G; Kovacs K; Horvath E; Borboli N; Piaditis G
    Pituitary; 2001 Sep; 4(4):215-21. PubMed ID: 12501971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
    Tampanaru-Sarmesiu A; Stefaneanu L; Thapar K; Kovacs K; Donnelly T; Metz CN; Bucala R
    Arch Pathol Lab Med; 1997 Apr; 121(4):404-10. PubMed ID: 9140312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diffusivity in pituitary adenoma: 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation.
    Hiwatashi A; Togao O; Yamashita K; Kikuchi K; Obara M; Yoshiura T; Honda H
    Br J Radiol; 2016 Jul; 89(1063):20150755. PubMed ID: 27187598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advancements in the molecular biology of pituitary adenomas.
    Zheng AC; Wang EJ; Aghi MK
    Expert Rev Endocrinol Metab; 2022 Jul; 17(4):293-304. PubMed ID: 35702013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.
    Asa SL; Bamberger AM; Cao B; Wong M; Parker KL; Ezzat S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2165-70. PubMed ID: 8964846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers.
    Almeida JP; Stephens CC; Eschbacher JM; Felicella MM; Yuen KCJ; White WL; Mooney MA; Bernat AL; Mete O; Zadeh G; Gentili F; Little AS
    Pituitary; 2019 Oct; 22(5):514-519. PubMed ID: 31401793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.
    Aylwin SJ; King A; Blenke A; Geddes JF; Wood DF; Monson JP; Burrin JM
    Eur J Endocrinol; 1998 Oct; 139(4):378-86. PubMed ID: 9820613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging.
    Lee JYK; Cho SS; Zeh R; Pierce JT; Martinez-Lage M; Adappa ND; Palmer JN; Newman JG; Learned KO; White C; Kharlip J; Snyder P; Low PS; Singhal S; Grady MS
    J Neurosurg; 2018 Aug; 129(2):390-403. PubMed ID: 28841122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
    Alexander JM; Swearingen B; Tindall GT; Klibanski A
    J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current pathological classification of pituitary adenomas.
    Saeger W
    Acta Neurochir Suppl; 1996; 65():1-3. PubMed ID: 8738481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.